Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Airway Stenosis

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 16, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2030

Conditions
Central Airway Obstruction
Interventions
COMBINATION_PRODUCT

Paclitaxel-Coated Pulmonary Balloon Catheter

Subjects with benign airway stenosis will be treated by Airiver pulmonary DCB at index procedure

Trial Locations (1)

0101

RECRUITING

Tbilisi State Medical University, Tbilisi

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Libra Medical

OTHER

lead

Airiver Medical, Inc.

INDUSTRY

NCT05895305 - Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Airway Stenosis | Biotech Hunter | Biotech Hunter